-Vikalp Once again, India is under pressure from the US to revise its patent law. Anyone familiar with the activities of the United States Trade Representatives (USTR) would know that this is nothing new. It has been among the USTR's primary mandates to use trade restrictions in order to persuade (to put it mildly) countries to strengthen their IPR laws. There is, however, a qualitative difference between the actions it has...
More »SEARCH RESULT
Total Matching Records found : 3852
Solar power can be the game-changer for inclusive growth -Vikas Gupta
-The Indian Express With the positive intent and progressive action from the new government, the country is excited about entering a new era of growth & revolutionary transformation. This can happen faster and more effectively if the whole ecosystem is geared for it. And most important component of the ecosystem are the people, who are the primary beneficiaries as well as the key catalysts to stimulate this growth and transformation. Hence,...
More »Scheming against the poor -TK Rajalakshmi
-Frontline The Left and other national parties protest against the NDA government's attempts to dilute the MGNREGS by limiting its budget and reducing its reach. IN a rare show of solidarity, representatives of several political parties took issue with the Bharatiya Janata Party-led National Democratic Alliance (NDA) government on its controversial proposal to restructure the Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS). The opposition, which was initially confined to the...
More »High uranium content found in Punjab soil -Tomojit Basu
-The Hindu Business Line BARC finds 91.77 ppm of the material in DAP; fertiliser industry says it can't be blamed When the Bhabha Atomic Research Centre (BARC) found high levels of uranium in fertiliser and soil samples from the Malwa region of Punjab last week, activists in the area were not surprised. They have long been warning about environmental contamination due to excessive phosphate fertiliser use. Local reports indicated that BARC found uranium...
More »Generic drug makers get a boost from SC ruling -Ramnath Subbu
-The Hindu In a significant development for the pharmaceutical industry, the Supreme Court has rejected multinational Bayer's appeal to block production and sales of the low cost version of its kidney cancer drug, sorafenib tosylate (branded as Nexavar), by Natco Pharmaceuticals. Hyderabad-based Natco was granted the first and to date only compulsory licence (CL) by the government in 2012 to make and sell a patented drug at a fraction of the...
More »
